Tempest Therapeutics TPST
NASDAQ TPST
$0.80 -0.01 (-0.92%)
As of: Oct 2, 2026 · 11:04 AM EDT

Tempest Therapeutics (TPST) Capital Expenditures (2012 - 2024)

Updated

Tempest Therapeutics (TPST) posted Capital Expenditures of $3,000 for Q4 2024, down 57.1% from $7,000 a year earlier and down 80.0% from the prior quarter.

Analysis

Tempest Therapeutics (TPST) Capital Expenditures (2012 - 2024) Analysis & Trends

For FY2024, Tempest Therapeutics' Capital Expenditures came in at $435,000, up 155.9% from FY2023.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of 1.8% (FY2019 to FY2024).
  • In prior years, Tempest Therapeutics' Capital Expenditures was $170,000 in FY2023 (-69.8%), $562,000 in FY2022 (+316.3%), $135,000 in FY2021 (+170.0%) and $50,000 in FY2020 (-87.4%).
  • Quarterly Capital Expenditures has run from a low of $3,000 in Q1 2022 to a high of $356,000 in Q4 2022 over five years.
  • On a year-over-year basis, Capital Expenditures increased in three of the last five quarters, with growth averaging 49.2%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2021, with growth of 536.4%; the weakest was Q4 2023, with a decline of 98.0%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $15,000 (Q3 2024), $249,000 (Q2 2024) and $168,000 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Tempest Therapeutics 4.09 Mn -26.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3,000.00
Sep 30, 2024 15,000.00
Jun 30, 2024 249,000.00
Mar 31, 2024 168,000.00
Dec 31, 2023 7,000.00
Jun 30, 2023 117,000.00
Mar 31, 2023 46,000.00
Dec 31, 2022 356,000.00
Sep 30, 2022 108,000.00
Jun 30, 2022 95,000.00
Mar 31, 2022 3,000.00
Dec 31, 2021 27,000.00
Sep 30, 2021 24,000.00
Jun 30, 2021 70,000.00
Mar 31, 2021 14,000.00
Dec 31, 2020 5,000.00
Sep 30, 2020 8,000.00
Jun 30, 2020 11,000.00
Mar 31, 2020 26,000.00
Dec 31, 2019 33,000.00
API Access

Tempest Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TPST&period=max&api_key=YOUR_API_KEY